GL1X · GenesisL1 explorer

Ligand · NU2

NU2 · (3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione

NU2, (3~{R},6~{R})-6-[(2~{S})-butan-2-yl]-3-(2,3-dihydro-1~{H}-inden-2-yl)-1-[(1~{R})-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxidanylidene-ethyl]piperazine-2,5-dione (C27 H34 N4 O5, 494.6 g/mol), in the MolNFT structures on…

Component
NU2
Formula
C27 H34 N4 O5
Class
ligand
Structures
2
PDB entries
1

Binding sites

NU2 in 2 structures; the first of them:

  • 6TPK · Crystal structure of the human oxytocin receptor · NU2 A1501 · binds VAL88, GLN92, GLN96, LYS116, GLN119, MET123, GLN171, PHE175 and 10 more
  • 6TPK · Crystal structure of the human oxytocin receptor · NU2 A1501 · binds GLN92, LYS116, GLN119, MET123, GLN171, PHE175, ILE201, ILE204 and 5 more

Residues it binds most

GLN 2, PHE 2, ILE 2, MET 2, ALA 2, LYS 2, TRP 2, VAL 1, SER 1 (residue and the binding sites it lines).

Found with

  • CLR · Cholesterol
  • PEG · Di(hydroxyethyl)ether

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.